长效纳米药物用于治疗大脑疾病
概括
使用纳米技术的长效药物输送系统 (LADDS) 克服了血液-大脑屏障,可持续向大脑输送药物. 这些先进的系统为慢性神经疾病提供了精确,持久的干预措施,超越了暂时的症状管理.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 血脑屏障 (BBB) 和短的药物半衰期限制了神经系统疾病的有效治疗.
- 脑疗法通常需要频繁和侵入性给药.
研究的目的:
- 审查持续向大脑药物输送的原则和纳米平台.
- 分析释放机制和纳米载体平台,以控制药理动力学和BBB透.
主要方法:
- 扩散,降解和刺激响应释放机制的分析.
- 对用于中枢神经系统药物输送的主要纳米载体平台的调查.
- 在神经系统疾病的临床前模型中应用的评估.
主要成果:
- 长效药物递送系统 (LADDS) 显示出持续,局部神经保护的潜力.
- 在中风,阿尔茨海默病,质瘤和TBI模型中的应用显示了调制的慢性病理学.
- 翻译的关键挑战包括生物相容性,可扩展性和监管批准.
结论:
- 与纳米技术集成的LADDS为神经药理学提供了一种变革性的方法.
- 未来的系统可能包括人工智能,生物响应材料和生物电子混合体,用于个性化治疗.
- 这些系统有望将重点转移到慢性脑疾病的持久性,恢复性干预.
更多相关视频
06:19Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
2.9K
09:06Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
12.6K
相关概念视频
Forces Acting on Chromosomes
4.0K
During mitosis, chromosome movements occur through the interplay of multiple piconewton level forces. In prometaphase, these forces help in chromosome assembly or congression at the equatorial plane, eventually leading to their alignment at the metaphase plate. The forces acting on the chromosomes are space and time-dependent; therefore, they vary with the position of the chromosomes as the cell progresses through mitosis.
Microtubules and motor proteins exert two types of forces on...
Microtubules and motor proteins exert two types of forces on...
4.0K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.9K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.9K
Drugs Acting on Autonomic Ganglia: Stimulants
2.1K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.1K
Drugs Acting on Autonomic Ganglia: Blockers
1.7K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.7K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.7K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.7K
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.6K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.6K
